logo
Faster than sound, undetectable by radar…, DRDO's hypersonic missile can bypass defenses, can fly at a speed of…, and strike deep into China and Pakistan

Faster than sound, undetectable by radar…, DRDO's hypersonic missile can bypass defenses, can fly at a speed of…, and strike deep into China and Pakistan

India.com22-05-2025

India is on the verge of creating a major milestone in the defense sector. The Defence Research and Development Organisation (DRDO) is getting ready to launch an indigenous hypersonic missile that could become one of the fastest and most powerful weapons in the world. This missile is expected to fly at a speed of Mach 5, that's around 6,120 kilometers per hour. Such a development would significantly boost India's status as a global military power. Dr. Sudhir Kumar Mishra, a senior DRDO scientist and former CEO of BrahMos Aerospace, recently confirmed this. According to him, the hypersonic engine was successfully tested a few weeks ago, and the full system will be revealed soon. What is a Hypersonic Missile?
Hypersonic missiles are weapons that can fly at speeds five times faster than the speed of sound or even more. That means speeds ranging from Mach 5 to Mach 25 (roughly 6,120 to 24,140 km/h). Their incredible speed, ability to change direction mid-flight, and the fact that they travel at lower altitudes make them extremely hard to detect or stop with current air defense systems.
There are two main types of hypersonic missiles:
Hypersonic Glide Vehicles (HGV): These are launched into the upper atmosphere using a rocket. After reaching high altitudes, they glide at incredible speeds toward their target, often changing direction during flight, which makes them very difficult to track.
Hypersonic Cruise Missiles: These use scramjet engines (supersonic combustion ramjets), which compress incoming air and mix it with fuel to create high-speed thrust. These missiles fly at lower altitudes and can hit targets with high precision. DRDO's Latest Breakthrough in Hypersonic Technology
On May 16, 2025, Dr. Sudhir Kumar Mishra made a significant announcement during a media event that DRDO has successfully tested an indigenous hypersonic engine. The ground test of this scramjet engine was conducted on April 25 at the Scramjet Connect Test Facility in Hyderabad. Impressively, the engine ran continuously for over 1,000 seconds (more than 16 minutes), marking the longest scramjet engine test ever done globally. With this, India now stands alongside countries like the USA, Russia, and China in advanced hypersonic technology. Joint Development with Public and Private Sectors
This advanced missile is being developed by DRDO's Dr. A.P.J. Abdul Kalam Missile Complex in Hyderabad in collaboration with other DRDO labs and private Indian companies. It will have a range of over 1,500 kilometers and can carry a variety of warheads, making it a highly flexible weapon system for the Indian armed forces. Key Features of the DRDO Hypersonic Missile
Indigenous Scramjet Engine: The missile is powered by a fully Indian-developed scramjet engine. It is built to maintain hypersonic speeds with key features like advanced thermal management, propulsion stability, and high-temperature endurance. Ceramic Thermal Barrier Coatings (TBCs) are used to handle extreme heat.
Endothermic Fuel: DRDO, in partnership with Indian private firms, has developed a special fuel that helps keep the engine cool and improves ignition. This results in better performance and efficiency of the missile.
Incredible Speed and Maneuverability: The missile can fly at Mach 5, change direction mid-flight, and operate at low altitudes making it extremely hard to detect or intercept by enemy defense systems.
Extended Range: With a range of over 1,500 kilometers, this missile can strike both tactical and strategic targets. It is capable of carrying both conventional and nuclear warheads.
Fully Made in India: From the launcher and engine to the navigation system, every major component of this missile has been developed indigenously by DRDO.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How dengue mosquitoes outsmart even scientists
How dengue mosquitoes outsmart even scientists

Time of India

time28 minutes ago

  • Time of India

How dengue mosquitoes outsmart even scientists

How dengue mosquitoes outsmart even scientists - their secret hunting techniques revealed Chethan Kumar TNN Updated: Jun 23, 2025, 18:12 IST IST While the dengue mosquito is a smarter predator than previously thought — it can detect you with its legs, too — Indian scientists have detected that a stealthy group of immune cells could be the unsung heroes in fighting the infection It's tough to outsmart a mosquito out for your blood. Here's some consolation. The buzzing insect outsmarts even supersmart scientists. 'Aedes aegypti', the mosquito behind dengue , Zika, and yellow fever , hunts down its prey — humans — primarily by its sense of smell. So, when researchers from the Rockefeller University stripped Aedes aegypti of its primary olfactory gene, Orco — knocking out their sense of smell — they reckoned the female mosquito will lose her hunting instinct. But she was smarter than they were. As a new study published in Science Advances details, when deprived of their olfactory power, Aedes use their ability to sense body heat. Typically, it's the mosquito's antennae that detects odours and heat. But Orco mutants deploy their forelegs to detect human skin temperature.

Gene-edited rice may pose IPR risks, scientists say in letter to PM
Gene-edited rice may pose IPR risks, scientists say in letter to PM

Business Standard

time35 minutes ago

  • Business Standard

Gene-edited rice may pose IPR risks, scientists say in letter to PM

A group of scientists calling themselves the 'Agricultural Scientists Manch' have written to the Prime Minister denouncing the recent release of India's first genetically edited rice varieties, stating that the technology used—CRISPR-Cas9—could face intellectual property rights (IPR) issues, potentially negating the real advantage Indian farmers could derive from genome-edited rice. The Centre has repeatedly clarified that all IPR issues related to gene editing are being thoroughly addressed, and a panel has been formed for this purpose. It has also assured that the government will acquire the necessary licences for gene-editing technologies and that no additional burden will fall on Indian farmers. The letter, signed by nearly 20 former and current scientists including Sharad Nimbalkar, former vice-chancellor of Panjabrao Deshmukh Agriculture University, Akola, stated that although CRISPR-Cas9 is a highly precise technology, it can still go off-track, potentially causing severe undesirable consequences. It also warned that large-scale use of gene-edited rice could contaminate India's native rice germplasm. The scientists further expressed concern that unresolved IPR issues could lead to Indian farmers becoming dependent on foreign seed technologies. They added that the newly released rice varieties were cleared without adequate evaluation. The letter was also marked to Agriculture Minister Shivraj Singh Chouhan, Environment Minister Bhupender Yadav, Health Minister Jagat Prakash Nadda and Science and Technology Minister Jitendra Singh. Last month, in a significant development, the government released two genome-edited rice varieties for the first time in the country. These varieties are expected to increase per-hectare yields by up to 30 per cent and mature 15–20 days earlier than existing varieties.

Meril Launches MyClip, Transcatheter-Edge-to-Edge Repair (TEER) System in India
Meril Launches MyClip, Transcatheter-Edge-to-Edge Repair (TEER) System in India

Mint

timean hour ago

  • Mint

Meril Launches MyClip, Transcatheter-Edge-to-Edge Repair (TEER) System in India

Meril Life Sciences, a global med-tech company, launched MyClip, a Transcatheter Edge-To-Edge Repair (TEER) system, on June 14. The Structural Heart Innovation event, held at Meril Academy, Vapi, Gujarat, from June 13–15, 2025, gathered over 150 Indian interventional cardiologists,cardiac imaging experts and international figures such as Prof. Ottavio Alfieri, Prof. Francesco Maisano, and Prof. Agricola. The introduction to MyClip indicates developments in structural heart solutions in India and reflects Meril's commitment to accessible cutting-edge cardiac care. MyClip TEER System is designed for patients with severe Mitral Regurgitation (MR) who face high surgical risk due to conditions such as hypertension, diabetes, obesity, advanced age, physical frailty, enlarged or weak heart, and patients with kidney, lung and liver problems. Untreated MR can have a significant mortality rate, with over 50% of patients not surviving without timely intervention, and a one-year mortality rate that can reach 57%. The MyClip TEER System allows for the precise closure of the mitral valve flaps, which can help prevent the backward flow of purified blood into the lungs. The procedure is minimally invasive, typically lasts about an hour, and may allow patients to return home within 3–5 days. Following discharge, patients may resume daily activities like walking and non-strenuous work relatively soon after the procedure. The COAPT Study, published in the New England Journal of Medicine (NEJM), reported that patients who received device-based therapy for mitral regurgitation experienced significantly better outcomes compared to those receiving standard medical treatment. Within 24 months, the hospitalisation rate for heart failure was reduced to 35.8% per patient-year in the device group, compared to 67.9% in the control group. Additionally, mortality within the same period was notably lower in the device group, at 29.1%, compared to 46.1% in the control group. Currently, approximately 150 TEERprocedures are performed annually in India, with the majority of patients falling in the age group of 30 to 60 years. These statistics bring to light a pressing need for early and effective intervention in younger demographics. In his inaugural speech, Sanjeev Bhatt, Senior Vice President of Corporate Strategy at Meril Life Sciences, said, 'In India, around 1.5 million people are known to have severe mitral regurgitation. Of these at least 1.2 million are post myocardial infarction (MI or a heart attack) or due to heart failure. Introduction of the MyClip TEER system marks a pivotal shift and we're witnessing early adoption. Meril's efforts in training cardiologists and building TEE-based imaging expertise are crucial steps in scaling this life-saving therapy across the country." 'With MyClip, Meril is reshaping the country's role in global medtech. This homegrown innovation is a testament to what Indian science, engineering, and clinical collaboration can achieve together. Meril's nationwide public awareness campaign #TreatmentZarooriHai with brand ambassador MS Dhoni aims to educate patients and families about the life-saving value of timely intervention in mitral valve regurgitation,' Mr. Bhatt added. The two-day Structural Heart Innovation scientific program featured case demonstrations, interactive hands-on workshops, and presentations by leading Interventional Cardiologists and Echocardiologists. The event concluded with a call to build a sustainable M-TEER ecosystem in India, focused on accessibility, clinical excellence, and continuous innovation.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store